0.722
Iterum Therapeutics Plc (ITRM) 最新ニュース
Technical analysis overview for Iterum Therapeutics plc stockDividend Hike & Low Risk Growth Stock Ideas - Newser
Ranking Iterum Therapeutics plc among high performing stocks via toolsJuly 2025 Recap & Safe Capital Investment Plans - Newser
How to use a screener to detect Iterum Therapeutics plc breakoutsMarket Growth Review & High Conviction Investment Ideas - Newser
Iterum Therapeutics plc stock trend forecastChart Signals & High Win Rate Trade Alerts - Newser
News impact scoring models applied to Iterum Therapeutics plcGDP Growth & Daily Entry Point Trade Alerts - Newser
Developing predictive dashboards with Iterum Therapeutics plc data2025 Price Momentum & Weekly High Potential Alerts - Newser
Will Iterum Therapeutics plc stock recover after recent dropTrade Entry Report & Risk Adjusted Swing Trade Ideas - Newser
Live market analysis of Iterum Therapeutics plcJuly 2025 Sentiment & Low Drawdown Momentum Trade Ideas - Newser
Is Iterum Therapeutics plc a candidate for recovery playMarket Volume Summary & Consistent Return Investment Signals - Newser
How to manage a losing position in Iterum Therapeutics plcTrade Risk Assessment & High Win Rate Trade Alerts - Newser
Is Iterum Therapeutics plc forming a bottoming base2025 Market Outlook & Daily Stock Momentum Reports - Newser
Will Iterum Therapeutics plc continue its uptrendMarket Sentiment Summary & Proven Capital Preservation Methods - Newser
Exit strategy if you’re trapped in Iterum Therapeutics plcPortfolio Update Summary & Entry Point Strategy Guides - Newser
Advanced analytics toolkit walkthrough for Iterum Therapeutics plc2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
Should you wait for a breakout in Iterum Therapeutics plcMarket Volume Report & Safe Swing Trade Setups - Newser
Will breakout in Iterum Therapeutics plc lead to full recoveryWatch List & Real-Time Buy Signal Alerts - Newser
Is Iterum Therapeutics plc building a consolidation baseInsider Selling & High Win Rate Trade Tips - Newser
Is Iterum Therapeutics plc reversing from oversold territoryWeekly Trend Recap & Short-Term Swing Trade Alerts - Newser
Analysts Backtest Strategies on Iterum Therapeutics plc With Promising Results getLinesFromResByArray error: size == 0 - kangso.co.kr
Measuring Iterum Therapeutics plc’s beta against major indicesMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser
What machine learning models say about Iterum Therapeutics plcWeekly Trade Summary & AI Enhanced Trade Execution Alerts - Newser
Custom strategy builders for tracking Iterum Therapeutics plcNew Guidance & Free Accurate Trade Setup Notifications - Newser
Intraday pattern recognizer results for Iterum Therapeutics plcPrice Action & Reliable Price Breakout Signals - Newser
Detecting support and resistance levels for Iterum Therapeutics plcTrade Analysis Report & Expert-Curated Trade Recommendations - Newser
What moving averages say about Iterum Therapeutics plcTrade Volume Summary & Low Drawdown Momentum Ideas - Newser
Will Iterum Therapeutics plc bounce back from current supportMarket Movement Recap & Daily Chart Pattern Signal Reports - Newser
Analyzing Iterum Therapeutics plc with multi timeframe chartsJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - Newser
What are Iterum Therapeutics plc’s earnings expectationsTrade Entry Report & Safe Entry Trade Reports - theviewers.co.kr
Published on: 2025-08-23 13:56:27 - Newser
Iterum Therapeutics plc Crosses 200 Day MA — Signal or NoiseJuly 2025 Gainers & AI Optimized Trade Strategies - classian.co.kr
Using Bollinger Bands to evaluate Iterum Therapeutics plc2025 Trade Ideas & Free AI Powered Buy and Sell Recommendations - Newser
Iterum Therapeutics plc Recovers — But Is It SustainableJuly 2025 Highlights & Weekly Momentum Stock Picks - beatles.ru
Earnings call transcript: Iterum Therapeutics Q2 2025 reveals EPS miss, stock dips - Investing.com
Iterum Therapeutics shares fall 10.11% intraday despite launching ORLYNVAH for uUTIs. - AInvest
Iterum Therapeutics plc (NASDAQ:ITRM) Q2 2025 Earnings Call Transcript - MSN
Iterum Therapeutics Launches New Antibiotic ORLYNVAH - TipRanks
Fibonacci Support Holding Strong in Iterum Therapeutics plcJuly 2025 Macro Moves & High Accuracy Buy Signal Tips - newsyoung.net
Iterum Therapeutics shares fall 5.42% intraday despite launching ORLYNVAH for uUTIs. - AInvest
ITRM Reports Results - AOL.com
Iterum launches first oral penem antibiotic for urinary tract infections - Investing.com
Iterum Therapeutics launches ORLYNVAH for uncomplicated urinary tract infections. - AInvest
Iterum Therapeutics Launches ORLYNVAH™: First Oral Penem Antibiotic Approved for Uncomplicated UTIs in Over 25 Years - Quiver Quantitative
Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S. - MarketScreener
大文字化:
|
ボリューム (24 時間):